Revenue and EBITDA Breakdown

Medical

Oncology

$196.6

(71.4%)

Cancer Center

Services

$72.7

(26.4%)

Other

$6.2

(2.2%)

Cancer Center Services

$322.7

(13.1%)

For 9 months ended September 30, 2003 Annualized

Net Operating RevenueTotal = $2,456.8 mm

Medical

Oncology

$2,075.8

(84.5%)

Other

$58.3

(2.4%)

EBITDA (Pre-Corporate)Total = $275.5 mm Total EBITDA margin: 11.2%

Previous slide

Next slide

Back to first slide

View graphic version